NASDAQ · Financial Statements
Cocrystal Pharma, Inc. (COCP) Financial Statements
$1.07
NASDAQ: COCP
Market Cap $14.75M
Overview Financials Dividend Cocrystal Pharma, Inc. most recently reported annual revenue of $0, net profit of $-9.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-14.0M $-39.0M $-19.0M $-18.0M $-9.0M Net Profit $-14.0M $-39.0M $-18.0M $-18.0M $-9.0M EPS $-1.85 $-4.77 $0.00 $-1.72 $-0.78 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $79.0M $41.0M $31.0M $13.0M $10.0M Total Liabilities $2.0M $1.0M $5.0M $4.0M $3.0M Cash $59.0M $37.0M $26.0M $10.0M $7.0M Borrowings $1.0M $0 $2.0M $2.0M $2.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-13.0M $-21.0M $-15.0M $-16.0M $-8.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $26.0M $-22.0M $-11.0M $-16.0M $-3.0M Free Cash Flow $-13.0M $-22.0M $-15.0M $-16.0M $-8.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.03 EV / EBITDA -1.58 FCF Yield -51.65% Quick Ratio 1.24 Interest Coverage 0.00 Return 1Y -43.53% Return 3Y -62.06% Return 5Y -92.79%
Screens featuring this stock